Furthermore, Kim et al25 reported that miR‐1208 could enhance cisplatin sensitivity by targeting TBCK in renal cancer cells, which indicates that miR‐1208 may be a tumour suppressor gene. The gene discussed is TBCK; the disease is renal carcinoma.